Avosentan reduces albumin excretion in diabetics with macroalbuminuria.
Wenzel RR, Littke T, Kuranoff S, Jürgens C, Bruck H, Ritz E, Philipp T, Mitchell A, SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators.
J Am Soc Nephrol. 2009 Mar; 20(3):655-64. Epub 2009 Jan 14.
[J Am Soc Nephrol. 2009]